Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:18:51 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Q:NKTX - NKARTA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NKTX - Q5.41.91·2.000.11.91-0.09-4.51,049.61,7563,4242.00  2.0171  1.897.55  1.3118:53:01Jun 0615 min RT 2¢

Recent Trades - Last 10 of 3424
Time ETExPriceChangeVolume
18:53:01Q1.94-0.0632
16:30:30Q1.91-0.0910
16:29:46Q1.91-0.0910
16:16:23Q1.91-0.095
16:10:03Q1.91-0.091
16:10:03Q1.91-0.091
16:09:43Q1.90-0.102
16:04:15Q1.91-0.091
16:04:13Q1.91-0.091
16:02:34Q1.91-0.09148

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-06 08:52U:NKTXNews ReleaseNkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
2025-05-14 16:01U:NKTXNews ReleaseNkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
2025-04-01 08:01U:NKTXNews ReleaseNkarta to Participate in an April Investor Conference
2025-03-26 16:01U:NKTXNews ReleaseNkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
2025-02-25 08:01U:NKTXNews ReleaseNkarta to Participate in March Investor Conferences
2024-12-05 06:01U:NKTXNews ReleaseNkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
2024-11-26 07:02U:NKTXNews ReleaseNkarta to Participate in an Upcoming Investor Conference
2024-11-12 08:02U:NKTXNews ReleaseNkarta to Participate in an Upcoming Investor Conference
2024-11-07 16:02U:NKTXNews ReleaseNkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
2024-09-03 16:01U:NKTXNews ReleaseNkarta to Participate in Upcoming Investor Conference
2024-08-13 21:04U:NKTXNews ReleaseCorrection: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-08-13 16:01U:NKTXNews ReleaseNkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-07-24 06:00U:NKTXNews ReleaseNkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus